Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs

Published:2023-02 Issue: Volume:181 Page:106362
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Deng Feng,Sjöstedt Noora^ORCID,Santo Mariangela,Neuvonen Mikko,Niemi Mikko,Kidron Heidi^ORCID

Funder

Svenska Kulturfonden

Syöpäsäätiö

Academy of Finland

Biocenter Finland

Suomen Kulttuurirahasto

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference74 articles.

1. Statin-induced myopathy: a review and update;Abd;Expert Opin. Drug Saf.,2011

2. Electrocardiographic characterization of the QTc interval in patients with advanced solid tumors: pharmacokinetic- pharmacodynamic evaluation of sunitinib;Bello;Clin. Cancer Res.,2009

3. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans;Blech;Drug Metab. Dispos.,2008

4. Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams;Brewer;Am. J. Cardiol.,2003

5. Abundance of hepatic transporters in caucasians: a meta-analysis;Burt;Drug Metab. Dispos.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors;Journal of Medicinal Chemistry;2024-09-04

2. Synergistic anticancer activity of Sulphoraphane and Teriflunomide co loaded lignin nanoparticles against triple negative breast cancer: Targeted nanoparticle delivery and drug repurposing;Medical Hypotheses;2024-08

3. Survey of Pharmaceutical Industry’s Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group;Drug Metabolism and Disposition;2024-05-02

4. Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer;International Journal of Molecular Medicine;2024-02-27

5. Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance;Pharmaceutics;2023-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3